Medigen Vaccine Biologics

Bio & Pharma Samsung Biologics bags $514 mn CMO contract from US pharma

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...

Bio & Pharma Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Korean stock market Samsung Biologics shares fly high to be Korea’s third most valuable firm

Samsung Biologics Co., the world’s largest contract drugmaker, has become South Korea’s third most valuable stock on the country’s...

Earnings Samsung Biologics posts record 2024 sales, operating profit as it goes global

South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, on Wednesday posted its largest-ever annual sales and operating p...

Bio & Pharma Lotte Biologics eyes first ADC CDMO order in 2025

SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...

Bio & Pharma Samsung Biologics signs $1.4 bn CMO deal with European pharma

South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...

Bio & Pharma Samsung Biologics signs initial deal with LigaChem Bio on ADC production

Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences I...

Bio & Pharma SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

Bio & Pharma Samsung Biologics wins $668 million CDMO deal with European pharma

Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...

Bio & Pharma SK Bioscience's SKYCellflu approved in Indonesia

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

Korean startups Enormous market ahead for Hopae, S.Korean DID pioneer

To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...

Bio & Pharma SK Bioscience sells stake in US vaccine developer Novavax

SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...

Bio & Pharma IMBiologics transfers autoimmune disease drug tech to Huadong Pharma

South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...

Korean stock market Biotech stocks, foreigners’ top pick in Korea amid panic selling

Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...

Bio & Pharma Samsung’s biotech duo on a roll with $1.1 bn CMO order

Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract man...

Bio & Pharma Lotte Biologics targets $1.1 billion in sales with new bio plants

South Korean biopharmaceutical company Lotte Biologics Co. said on Wednesday it is aiming for 1.5 trillion won ($1.1 billion) in annual sales by 203...

Mergers & Acquisitions SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn

South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...

Bio & Pharma Samsung Biologics eyes windfall gain amid US-China row

SAN DIEGO – Samsung Biologics Co. is enjoying a stream of contract development and manufacturing order inquiries from big pharmaceutical compa...

Bio & Pharma EuBiologics gets WHO certification for cholera vaccine facility

South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...

Bio & Pharma SK Bioscience exports Sky Cellflu to Thailand

South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...

Bio & Pharma Samsung Biologics signs ADC CDO deal with LegoChem Bio

Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...

Bio & Pharma Lotte Biologics, NJ Bio to jointly develop ADC

South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...

Bio & Pharma SK Bioscience start to deliver Novavax COVID-19 vaccine

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

Bio & Pharma SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

Bio & Pharma Samsung Biologics reaches record-breaking annual orders

Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...

Bio & Pharma Korea to invest $200 mn in new drugs, vaccines by 2028

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...

Bio & Pharma GC Biopharma wins $10 mn order for flu vaccine in Thailand

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...

Bio & Pharma KAIST, IVI to collaborate on global vaccine research

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...

Bio & Pharma SK Bioscience to develop 2nd-generation Ebola vaccine

South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...

Bio & Pharma Lotte builds US antibody-drug conjugate plant with $82 mn

South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...